Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013, Article ID 631060, 4 pages
http://dx.doi.org/10.1155/2013/631060
Case Report

5-Alpha-Reductase 2 Deficiency in a Woman with Primary Amenorrhea

1Department of Internal Medicine, Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran
2The Persian Gulf Marine Medicine Biotechnology Research Center, Department of Endocrinology, Bushehr University of Medical Sciences, Bushehr, Iran
3Department of Internal Medicine, Shohadaye Khalije Fars Hospital, Bushehr University of Medical Sciences, Bushehr, Iran

Received 23 September 2013; Accepted 20 October 2013

Academic Editors: G. Aimaretti and O. Isozaki

Copyright © 2013 Nasrollah Maleki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. A. Hughes, C. Houk, S. F. Ahmed, and P. A. Lee, “Consensus statement on management of intersex disorders,” Archives of Disease in Childhood, vol. 91, no. 7, pp. 554–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. C. Walsh, J. D. Madden, M. J. Harrod, J. L. Goldstein, P. C. MacDonald, and J. D. Wilson, “Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias,” The New England Journal of Medicine, vol. 291, no. 18, pp. 944–949, 1974. View at Google Scholar · View at Scopus
  3. J. Imperato McGinley, L. Guerrero, T. Gautier, and R. E. Peterson, “Steroid 5α reductase deficiency in man: an inherited form of male pseudohermaphroditism,” Science, vol. 186, no. 4170, pp. 1213–1215, 1974. View at Google Scholar · View at Scopus
  4. C. Sultan, F. Paris, B. Terouanne et al., “Disorders linked to insufficient androgen action in male children,” Human Reproduction Update, vol. 7, no. 3, pp. 314–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. E. P. Jenkins, S. Andersson, J. Imperato-McGinley, J. D. Wilson, and D. W. Russell, “Genetic and pharmacological evidence for more than one human steroid 5α-reductase,” Journal of Clinical Investigation, vol. 89, no. 1, pp. 293–300, 1992. View at Google Scholar · View at Scopus
  6. L. Maimoun, P. Philibert, B. Cammas et al., “Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 2, pp. 296–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. D. Wilson, J. E. Griffin, and D. W. Russell, “Steroid 5α-reductase 2 deficiency,” Endocrine Reviews, vol. 14, no. 5, pp. 577–593, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Frade Costa, I. J. Prado Arnhold, M. Inacio, and B. B. Mendonca, “Normal bone density in male pseudohermaphroditism due to 5alpha- reductase 2 deficiency,” Revista do Hospital das Clinicas de Faculdade de Medicina da Universidade de Sao Paulo, vol. 56, no. 5, pp. 139–142, 2001. View at Google Scholar · View at Scopus
  9. V. Sobel, B. Schwartz, Y.-S. Zhu, J. J. Cordero, and J. Imperato-McGinley, “Bone mineral density in the complete androgen insensitivity and 5α-reductase-2 deficiency syndromes,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 3017–3023, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Imperato-McGinley, R. E. Peterson, T. Gautier, and E. Sturla, “Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5α-reductase deficiency,” The New England Journal of Medicine, vol. 300, no. 22, pp. 1233–1237, 1979. View at Google Scholar · View at Scopus
  11. P. T. Cohen-Kettenis, “Gender change in 46,XY persons with 5α-reductase-2 deficiency and 17β-hydroxysteroid dehydrogenase-3 deficiency,” Archives of Sexual Behavior, vol. 34, no. 4, pp. 399–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Milewich, B. B. Mendonca, I. Arnhold et al., “Women with steroid 5α-reductase 2 deficiency have normal concentrations of plasma 5α-dihydroprogesterone during the luteal phase,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 11, pp. 3136–3139, 1995. View at Google Scholar · View at Scopus
  13. M. D. Katz, L.-Q. Cai, Y.-S. Zhu et al., “The biochemical and phenotypic characterization of females homozygous for 5α-reductase-2 deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 11, pp. 3160–3167, 1995. View at Google Scholar · View at Scopus
  14. R. E. Peterson, J. Imperato McGinley, T. Gautier, and E. Sturla, “Male pseudohermaphroditism due to steroid 5α reductase deficiency,” American Journal of Medicine, vol. 62, no. 2, pp. 170–191, 1977. View at Google Scholar · View at Scopus
  15. B. B. Mendonca, M. Inacio, E. M. F. Costa et al., “Male pseudohermaphroditism due to steroid 5α-reductase 2 deficiency: diagnosis, psychological evaluation, and management,” Medicine, vol. 75, no. 2, pp. 64–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Griffin, M. J. McPhaul, D. W. Russell, and J. D. Wilson, “The androgen resistance syndromes: steroid 5-alpha-reductase 2 deficiency, testicular feminization, and related disorders,” in The Metabolic and Molecular Basis of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, Eds., p. 4117, McGraw-Hill, New York, NY, USA, 8th edition, 2001. View at Google Scholar
  17. G. Sasaki, K. Nakagawa, A. Hashiguchi, T. Hasegawa, T. Ogata, and M. Murai, “Giant seminoma in a patient with 5α-reductase type 2 deficiency,” Journal of Urology, vol. 169, no. 3, pp. 1080–1081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. E. M. F. Costa, B. B. Mendonca, M. Inácio, I. J. P. Arnhold, F. A. Q. Silva, and O. Lodovici, “Management of ambiguous genitalia in pseudohermaphrodites: new perspectives on vaginal dilation,” Fertility and Sterility, vol. 67, no. 2, pp. 229–232, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Price, J. A. H. Wass, and J. E. Griffin, “High dose androgen therapy in male pseudohermaphroditism due to 5α-reductase deficiency and disorders of the androgen receptor,” Journal of Clinical Investigation, vol. 74, no. 4, pp. 1496–1508, 1984. View at Google Scholar · View at Scopus
  20. T. O. Carpenter, J. Imperato-McGinley, S. D. Boulware et al., “Variable expression of 5α-reductase deficiency: presentation with male phenotype in a child of Greek origin,” Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 2, pp. 318–322, 1990. View at Google Scholar · View at Scopus
  21. B. S. Keenan, A. J. Eberle, J. T. Sparrow, N. G. Greger, and W. B. Panko, “Dihydrotestosterone heptanoate: synthesis, pharmacokinetics, and effects of hypothalamic-pituitary-testicular function,” Journal of Clinical Endocrinology and Metabolism, vol. 64, no. 3, pp. 557–562, 1987. View at Google Scholar · View at Scopus